Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
US Department of Justice
Boehringer Ingelheim
Cerilliant
Dow
Federal Trade Commission
Teva
Baxter
Fish and Richardson

Generated: December 12, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: amphotericin b

« Back to Dashboard

AMPHOTERICIN B

CASRN: 1397-89-3UNII: 7

Manufacturing Methods

<truncated in preview>

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Argus Health
Federal Trade Commission
Covington
US Department of Justice
Boehringer Ingelheim
Harvard Business School
Citi
Cantor Fitzgerald